Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Australian natural skincare company Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital
  • Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements
  • Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels
  • On the market, Skin Elements last traded at 10 cents per share

Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital.

The parties have signed a put option agreement, which will see LDA provide Skin Elements up to $20 million in committed equity capital over the next 36 months.

Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements and will receive funds for the issue of those shares.

Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels.

Last year, the natural skincare company applied for a Therapeutic Goods Administration (TGA) registration for its sanitising disinfectant, Invisi Shield — a hospital-grade disinfectant.

"Successful registration with the TGA will allow the company to make more
detailed and specific product and label claims in respect to Invisi Shield which has the potential to open up significant new commercial-scale sales and distribution opportunities," the company explained to the market.

"We are excited to have secured this $20 million equity funding facility from LDA Capital," Chairman Peter Malone said.

"LDA Capital has a track record of providing funding to help emerging growth
companies achieve their business goals, and we are delighted to see that LDA Capital shares the same positive view on the global growth potential of our Invisi Shield sanitising disinfectant and our range of natural skincare products as we do," he added.

On the market, Skin Elements is suspended and last traded at 10 cents per share.

SKN by the numbers
More From The Market Herald
Rhythm Biosciences (ASX:RHY) brings ColoSTAT trial to Queensland

" Proteomics International Laboratories (ASX:PIQ) to collaborate for world’s first endometriosis test

Proteomics International Laboratories (PIQ) has penned a research agreement to develop a non-invasive test for endometriosis.
ResApp Health (ASX:RAP) - CEO & Managing Director, Dr Tony Keating - The Market Herald

" ResApp Health (ASX:RAP) secures two deals to integrate its diagnostic test

ResApp Health (RAP) has secured two new agreements for its smartphone-based acute respiratory diagnostic test.
Paradigm Biopharmaceuticals (ASX:PAR) - Chairman & CEO, Paul Rennie - The Market Herald

" FDA requests further clarification from Paradigm Biopharmaceuticals (ASX:PAR)

The US Food and Drug Administration has requested further clarification from Paradigm Biopharmaceuticals (PAR) for its Investigational New Drug (IND) application.
Patrys (ASX:PAB) - CEO and Managing Director, Dr James Campbell - The Market Herald

" Patrys’ (ASX:PAB) clinical trials pushed back

Patrys’ (PAB) planned PAT-DX1 clinical trial will be postponed for up to six months due to global manufacturing and supply chain delays.